Moreover, the present study demonstrated that changes in ALT were significantly correlated with those in HOMA‐IR in patients without diabetes mellitus, suggesting that an improvement in insulin resistance, a known trigger for the onset/progression of MASLD,42 may contribute to the amelioration of liver injury. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.